The U.S. Patent and Trademark Office awarded a US patent, #7,842,006, to CFD Research Corporation (CFDRC) for an invention titled “Thrombectomy Microcatheter”.
Thrombectomy catheters facilitate fast-acting interventional therapies to remove blood clots in arteries. CFDRC's thrombectomy microcatheter uses ultrasonic acoustic streaming to disrupt blood clots, even in arteries that are too small for existing thrombectomy catheters. The novel microcatheter was developed by a CFDRC Biomedical Technology Branch team of engineers and scientists while working on a contract awarded by the National Institutes of Health (NIH) to develop improved treatments for stroke. The technology was designed through extensive use of computer simulations. Selected designs were fabricated and demonstrated for mixing and/or cleaning in CFDRC’s Bioengineering Laboratory.
“This technology is borne out of a unique marriage of our expertise in MEMS and biomedical engineering, and has the potential to dramatically improve patient outcome. With the added benefits of simplicity – no lasers, ultrasound generators or high pressure saline pumps found in competing technologies,” stated Dr. Kapil Pant, Director of Micro & Nano Biosystems at CFDRC “we anticipate significant interest from customers and partners, and are optimistic about the future of this unique technology.”
More information can be found on our Thrombectomy Catheter page.